Semaglutide and hospitalizations in patients with obesity and established cardiovascular disease
About The Study: In this prespecified exploratory analysis of the SELECT randomized clinical trial, the trial cohort had a high rate of hospital admissions. Treatment with once-weekly semaglutide was associated with significant reductions in hospital admissions and overall time spent in hospital, extending its benefits beyond cardiovascular risk reduction.
Corresponding Author: To contact the corresponding author, Stephen J. Nicholls, MD, email stephen.nicholls@monash.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamacardio.2025.4824)
Editor’s ...